Mata Nathan L.

Chief Scientific OfficerBELITE BIO, INC (BLTE) · full profile →Form 4 · filed May 7, 2026
Net Selling
Open-Market Buys
$0
Open-Market Sells
$154K
Net Open-Market Flow
-$154K
Transactions
6
6 non-derivative · 0 derivative

Non-Derivative Transactions (Table I)

DateActionSharesPriceValueOwned After
May 6, 2026Sell(S)8$151.57$1K2K
May 6, 2026Sell(S)424$152.67$65K1K
May 6, 2026Sell(S)128$153.42$20K1K
May 6, 2026Sell(S)240$154.41$37K866
May 6, 2026Sell(S)100$155.97$16K766
May 6, 2026Sell(S)100$156.00$16K666

Transaction Codes

S
Open-market sale

Data Source & Provenance

Parsed from a single SEC EDGAR Form 4 filing (accession 0001193125-26-211974) within minutes of acceptance. Every field above traces to the original document. Verify it directly: